Tempest Therapeutics Secures $2.5 Million Through Private Placement

Tempest Therapeutics has entered into a private placement agreement to secure $2.5 million in immediate capital, with an additional $5 million in potential proceeds tied to future warrant exercises. The financing aims to support the company balance sheet and involves the issuance of over 3.1 million shares and associated warrants.

The transaction includes 3,105,591 shares, or pre-funded warrants in lieu of common stock, paired with Series C and D warrants at a combined purchase price of $0.805 per share. According to a company announcement, the deal is expected to close on or about September 14, 2026, pending customary closing conditions.

Understanding the Financing Structure

The capital raise is split into two tiers: guaranteed upfront proceeds and conditional future funding. The $2.5 million is realized upon the initial closing, while the additional $5 million is contingent on the exercise of Series C and D warrants. These warrants are not guaranteed and remain subject to necessary stockholder approval before they can be exercised.

This structure allows the company to minimize immediate dilution while creating a path for future liquidity, provided the conditions for warrant exercise are met. In a private placement, companies issue warrants to provide institutional investors the right to purchase additional shares at a set price in the future.

Market Performance and Context

The financing news arrives as Tempest Therapeutics (TPST) navigates the current equity environment. As of September 14, 2026, the company stock was trading at $0.77, marking a 5.2% decline from the previous market close.

For investors and stakeholders, the primary concern remains the company's ability to reach its development milestones using the newly raised capital. By securing a mix of immediate cash and potential future funding, the firm aims to extend its operational runway, though the reliance on stockholder approval for the secondary tier of funding introduces a layer of uncertainty regarding the total eventual proceeds of the transaction.